Calendar Leap Therapeutics, Inc.

Equities

LPTX

US52187K2006

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
3.25 USD +2.52% Intraday chart for Leap Therapeutics, Inc. +16.07% -21.59%

Chart calendar Leap Therapeutics, Inc.

3.YHLqU3Q2GMndEXjyqE9pacTs1Jg47EHHldS90oMjqOs.Oh-faiJpe7CpPA6KzxkND6Gtu99r1SiO5bn2mMZamYIwSt4iR1xBsax8OQ~acff08d9c521eef36086acc8b92add9a

Upcoming events on Leap Therapeutics, Inc.

2024-05-14 Q1 2024 Earnings Release (Projected)
2024-08-08 Q2 2024 Earnings Release (Projected)
2024-11-13 Q3 2024 Earnings Release (Projected)
2025-03-23 Q4 2024 Earnings Release (Projected)

Past events on Leap Therapeutics, Inc.

2024-03-18 07:00 am Q4 2023 Earnings Release
2024-01-23 08:30 am Business Update Call
2024-01-20 06:30 am American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number: 104
2024-01-17 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
2024-01-10 04:30 pm JPMorgan Healthcare Conference
2023-11-28 08:00 am Piper Sandler Healthcare Conference
2023-11-13 07:00 am Q3 2023 Earnings Release
2023-09-13 03:10 pm Baird Global Healthcare Conference
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-08-14 07:00 am Q2 2023 Earnings Release
2023-06-15 Annual General Meeting
2023-06-05 12:30 pm American Society of Clinical Oncology Conference - Abstract Number: 4027
2023-05-15 07:00 am Q1 2023 Earnings Release
2023-03-24 07:00 am Q4 2022 Earnings Release
2023-03-15 Extraordinary Shareholders Meeting
2023-01-18 01:30 pm B. Riley Securities Oncology Conference
2023-01-17 09:00 am Acquisition of Flame Biosciences, Inc. by Leap Therapeutics, Inc. Call
2022-11-29 04:00 pm Piper Sandler Healthcare Conference
2022-11-14 07:00 am Q3 2022 Earnings Release
2022-11-10 09:00 am Society for Immunotherapy of Cancer Meeting - Abstract Number: 553

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
1,50
1,70
-11.76%
1,50
1,52
-1.63%
0,00
1,20
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-33,5
-32,7
-2.32%
-28,5
-30,7
6.95%
-41,4
-43,0
3.62%
-56,8
-55,9
-1.62%
-87,0
-87,9
0.95%

-71,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-32,9
-32,5
-1.23%
-27,5
-35,4
22.37%
-40,6
-41,1
1.07%
-54,4
-55,2
1.33%
-81,4
-83,8
2.86%

-69,8

Net income
Million USD
Released
Forecast
Spread
-33,3
-32,5
-2.33%
-37,6
-40,5
7.15%
-40,6
-41,1
1.13%
-54,6
-55,2
1.07%
-81,4
-83,8
2.86%

-69,8

EPS
USD
Released
Forecast
Spread
-14,7
-14,2
-3.52%
-6,30
-6,40
1.56%
-4,70
-4,92
4.47%
-4,80
-4,88
1.64%
-3,98
-3,50
-13.71%

-2,25

Announcement Date16/03/2012/03/2111/03/2224/03/2318/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,38
0,30
23.03%
0,00
0,15
-
0,00
0,00
-
0,00
0,00
-
0,00
1,20
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-10,5
-12,0
12.9%
-10,6
-11,3
5.59%
-16,9
-11,0
-53.35%
-15,3
-13,3
-15.03%
-13,9
-13,0
-6.93%
-42,7
-14,4
-196.56%
-14,7
-14,2
-3.11%
-14,8
-15,2
2.1%
-14,8
-15,7
5.31%

-16,1


-17,2


-18,3


-19,6


-18,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-10,8
-11,3
3.9%
-10,4
-11,0
5.77%
-17,0
-10,9
-56.83%
-15,1
-13,2
-14.29%
-12,0
-12,8
6.87%
-41,9
-13,4
-211.67%
-13,4
-13,6
1.74%
-13,7
-14,2
3.37%
-12,5
-14,9
16.13%

-15,7


-16,8


-18,0


-19,2


-17,2

Net income
Million USD
Released
Forecast
Spread
-10,8
-11,3
4.11%
-10,4
-11,0
5.77%
-17,0
-10,9
-56.83%
-15,1
-13,2
-14.29%
-12,1
-12,8
5.72%
-41,9
-13,4
-211.67%
-13,4
-13,6
1.74%
-13,7
-14,2
3.37%
-12,5
-14,9
16.13%

-15,7


-16,8


-18,0


-19,2


-17,2

EPS
USD
Released
Forecast
Spread
-0,80
-1,10
27.27%
-0,90
-1,00
10%
-1,50
-0,96
-56.25%
-1,30
-1,18
-10.17%
-1,00
-1,10
9.09%
-3,20
-0,86
-272.09%
-0,91
-0,90
-1.56%
-0,51
-0,58
11.76%
-0,20
-0,56
63.96%

-0,59


-0,62


-0,62


-0,49


-0,40

Announcement Date11/03/2213/05/2212/08/2214/11/2224/03/2315/05/2314/08/2313/11/2318/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LPTX Stock
  4. Calendar Leap Therapeutics, Inc.